In the present study, we hypothesized that the REMsuppressing effects of 5-HT 1A receptor stimulation would counteract the REM-disinhibiting effects of rapid tryptophan depletion (RTD), and vice versa. We administered RTD plus ipsapirone (10 mg, p.o.) The rapid tryptophan depletion (RTD) paradigm (Young et al. 1985;Delgado et al. 1990) allows researchers to study the consequences of 5-HT system deactivation. In humans and animals, RTD has been shown to cause significant (but transient) reductions in the levels of tryptophan (TRP) in the blood, and to reduce the amount of 5-HT in the brain (for review, see Moore et al. 2000). RTD typically consists of a day's worth of a low-TRP diet, followed by ingestion of a TRP-free amino acid load, and RTD, but not the control TRP-containing condition, has been associated with myriad clinical and physiological effects. Relapse of depressive mood following RTD in recently remitted depressed patients has been reported (Delgado et al. 1990). In healthy subjects, mood responses as well as other behavioral measures have been somewhat inconsistent (Young et al. 1985;Barr et al. 1997).The sleep abnormalities often associated with depression are consistent with the notion of a pathophysiologic deficiency in serotonergic function in depression (Maes and Meltzer 1995). There is strong preclinical and clinical evidence that serotonin plays a role in suppressing REM sleep (McGinty and Harper 1976;Honda and Semba 1994;Luebke et al. 1992;Portas et al. 1996).RTD apparently disinhibits REM sleep measures in serotonin reuptake inhibitor (SRI)-treated patients in full remission ) and in healthy male control subjects ), using two different The Effects of REM Sleep of RTD plus Ipsapirone S41 strengths of RTD (100% and 25%). In SRI-treated patients, both RTD doses also reversed the reduced total sleep time and prolonged sleep latency observed at baseline. In normal males, both RTD doses significantly decreased REM latency compared with baseline, as well as significantly reduced total and free plasma TRP concentrations.Agonists at the 5-HT 1A receptor, such as ipsapirone, have been shown to inhibit REM sleep both in healthy subjects and in depressed patients (Gillin et al. 1994;Gillin et al. 1996;, and this effect presumably reflects predominantly post-synaptic receptor activity. In the present study, we examined the competing effects of 5-HT depletion and 5-HT stimulation on sleep. We predicted REM sleep measures with RTD plus placebo would be significantly enhanced compared with baseline as shown in previous studies with RTD alone, and that the combination of RTD and ipsapirone would produce REM measures with values intermediate between those obtained with either 5-HT manipulation alone.
METHODS
SubjectsTen healthy male subjects between the ages of 20 to 39 years (28.7 Ϯ 1.9, mean Ϯ SD) were recruited from the general public in the San Diego region through the UCSD Mental Health Clinical Research Center (MH-CRC). Eight Caucasian-Americans and two AfricanAmericans completed the study after givin...